925672-85-1 Usage
General Description
1,6-Dibromo-3-isoquinolinamine is a chemical compound with the molecular formula C9H6Br2N2. It is a white to off-white crystalline solid that is insoluble in water but soluble in organic solvents. 1,6-DIBROMO-3-ISOQUINOLINAMINE is primarily used as an intermediate in the synthesis of pharmaceuticals and other organic compounds. It is also used as a reagent in chemical reactions, particularly in the production of heterocyclic compounds. 1,6-Dibromo-3-isoquinolinamine is classified as a bromo substituted heterocyclic compound and must be handled and stored with appropriate safety precautions, as it can be harmful if ingested, inhaled, or absorbed through the skin.
Check Digit Verification of cas no
The CAS Registry Mumber 925672-85-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,5,6,7 and 2 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 925672-85:
(8*9)+(7*2)+(6*5)+(5*6)+(4*7)+(3*2)+(2*8)+(1*5)=201
201 % 10 = 1
So 925672-85-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H6Br2N2/c10-6-1-2-7-5(3-6)4-8(12)13-9(7)11/h1-4H,(H2,12,13)
925672-85-1Relevant articles and documents
FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE
-
Page/Page column 54; 55, (2010/08/08)
The invention relates to thiazole compounds of Formula (I) and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein. The invention also relates to the therapeutic use of such thiazole compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.
HETEROCYCLIC MODULATORS OF PKB
-
Page/Page column 159-160, (2009/03/07)
The invention relates to heterocyclic compounds of Formula I and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein Formula (I). The invention also relates to the therapeutic use of such compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.
